Understanding how a virus can persist and potentially cause cancer
Official title: Mechanism For Merkel Cell Polyomavirus Persistence
Funded at University of Pittsburgh at Pittsburgh · NIH-11009996 · Data updated 2026-11-12
This study is looking into how the Merkel cell polyomavirus can stick around in the body and possibly cause cancer, helping us understand how it hides from the immune system and what that means for people dealing with chronic viral infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | January 10, 2024 |
| Project end | November 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $715,883 |
| NIH project number | 5R01AI177607-02 |
| Project ID | NIH-11009996 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with chronic infections related to MCPyV or those at risk for Merkel cell carcinoma.
✕Less likely to help
Patients who do not have any history of viral infections or cancers associated with MCPyV may not benefit from this research.
What this research studies
This research investigates the mechanisms by which Merkel cell polyomavirus (MCPyV) can persist in the body and lead to cancer. The study focuses on how the virus controls its replication and achieves latency, which allows it to evade the immune system. Using advanced technologies, researchers will analyze the interactions of viral proteins with the virus's genetic material to understand how these processes work at a molecular level. This could provide insights into chronic viral infections and their link to cancer development.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating cancers associated with chronic viral infections.
How similar studies have gone: Previous research has shown success in understanding latency mechanisms in other viruses, but this specific approach to MCPyV is relatively novel.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Chang, Yuan — University of Pittsburgh at Pittsburgh
- Study coordinator: Chang, Yuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.